Patents by Inventor Huiping Zhao

Huiping Zhao has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220009876
    Abstract: An improved method for synthesizing a compound according to formula (I) by reaction of a compound of formula (II) with a sulfinamide according to formula (III). The resultant compound is then reduced and hydrolyzed, and optionally alkylated or arylated to arrive at the compound according to formula (I).
    Type: Application
    Filed: October 31, 2019
    Publication date: January 13, 2022
    Inventors: Thais Motria SIELECKI-DZURDZ, Baoyu Ml, Huiping ZHAO, Sandhya KORTAGERE
  • Patent number: 10745386
    Abstract: Compounds of the formulas: wherein: R1-R4, X1, Y1, and A are as defined herein are provided. Pharmaceutical compositions of the compounds are also provided. In some aspects, these compounds are useful for the treatment of a disease or disorder. In some embodiments, the disease or disorder is a proliferative disease such as cancer.
    Type: Grant
    Filed: June 26, 2018
    Date of Patent: August 18, 2020
    Assignee: UNIVERSITY OF KANSAS
    Inventors: Brian S. J. Blagg, Huiping Zhao
  • Patent number: 10689344
    Abstract: Compounds of the formulas are provided: wherein variables Y1-Y5, X1-X5, A1-A4, X, y, n1, n2, and R1-R15 are as defined herein. Pharmaceutical compositions of the compounds are also provided. In some aspects, these compounds are useful for the treatment of a disease or disorder, including, for example, a proliferative disease, such as cancer.
    Type: Grant
    Filed: November 7, 2014
    Date of Patent: June 23, 2020
    Assignee: UNIVERSITY OF KANSAS
    Inventors: Brian S. J. Blagg, Huiping Zhao
  • Publication number: 20190023698
    Abstract: Compounds of the formulas: wherein: R1-R4, X1, Y1, and A are as defined herein are provided. Pharmaceutical compositions of the compounds are also provided. In some aspects, these compounds are are useful for the treatment of a disease or disorder. In some embodiments, the disease or disorder is a proliferative disease such as cancer.
    Type: Application
    Filed: June 26, 2018
    Publication date: January 24, 2019
    Applicant: University of Kansas
    Inventors: Brian S.J. BLAGG, Huiping ZHAO
  • Patent number: 10030006
    Abstract: Compounds of the formulas: wherein: R1-R4, X1, Y1, and A are as defined herein are provided. Pharmaceutical compositions of the compounds are also provided. In some aspects, these compounds are are useful for the treatment of a disease or disorder. In some embodiments, the disease or disorder is a proliferative disease such as cancer.
    Type: Grant
    Filed: November 11, 2014
    Date of Patent: July 24, 2018
    Assignee: UNIVERSITY OF KANSAS
    Inventors: Brian S. J. Blagg, Huiping Zhao
  • Patent number: 9994556
    Abstract: Provided herein are compounds of the formulas: which are 90-kDa heat shock protein inhibitors. Pharmaceutical compositions of the compounds are also provided. In some aspects, these compounds may be used for the treatment of diseases, including cancer, e.g., cancers of the breast, the prostate, and the head & neck.
    Type: Grant
    Filed: June 12, 2015
    Date of Patent: June 12, 2018
    Assignee: UNIVERSITY OF KANSAS
    Inventors: Jinbo Zhao, Huiping Zhao, Brian S. J. Blagg
  • Publication number: 20170253582
    Abstract: Provided herein are compounds of the formulas: which are 90-kDa heat shock protein inhibitors. Pharmaceutical compositions of the compounds are also provided. In some aspects, these compounds may be used for the treatment of diseases, including cancer, e.g., cancers of the breast, the prostate, and the head & neck.
    Type: Application
    Filed: June 12, 2015
    Publication date: September 7, 2017
    Inventors: Jinbo ZHAO, Huiping ZHAO, Brian S.J. BLAGG
  • Publication number: 20160289217
    Abstract: Compounds of the formulas: wherein: R1-R4, X1, Y1, and A are as defined herein are provided. Pharmaceutical compositions of the compounds are also provided. In some aspects, these compounds are are useful for the treatment of a disease or disorder. In some embodiments, the disease or disorder is a proliferative disease such as cancer.
    Type: Application
    Filed: November 11, 2014
    Publication date: October 6, 2016
    Applicant: University of Kansas
    Inventors: Brian S.J. BLAGG, Huiping ZHAO
  • Publication number: 20160272584
    Abstract: Compounds of the formulas are provided: wherein variables Y1-Y5, X1-X5, A1-A4, X, y, n1, n2, and R1-R15 are as defined herein. Pharmaceutical compositions of the compounds are also provided. In some aspects, these compounds are useful for the treatment of a disease or disorder, including, for example, a proliferative disease, such as cancer.
    Type: Application
    Filed: November 7, 2014
    Publication date: September 22, 2016
    Applicant: University of Kansas
    Inventors: Brian S.J. BLAGG, Huiping ZHAO
  • Patent number: 9120774
    Abstract: The disclosure provides novobiocin analogues with noviose replacements which are useful as Hsp90 inhibitors in the treatment of cancer.
    Type: Grant
    Filed: February 19, 2010
    Date of Patent: September 1, 2015
    Assignee: University of Kansas
    Inventors: Brian S. J. Blagg, Huiping Zhao, Alison Catherine Donnelly
  • Publication number: 20120252745
    Abstract: The disclosure provides novobiocin analogues with noviose replacements which are useful as Hsp90 inhibitors in the treatment of cancer.
    Type: Application
    Filed: February 19, 2010
    Publication date: October 4, 2012
    Inventors: Brian S. J. Blagg, Huiping Zhao, Alison Catherine Donnelly
  • Publication number: 20030072813
    Abstract: Compositions and methods for the treatment of vitiligo. The composition comprises at least one member selected from the group consisting of: Eclipta prostrata L., Angelica dahurica, Polygonum multiforum Thumb, Astragalus complanatus, Tribulus terrestris L., Lithospermum erythrorhizon sieb et zucc, Paris petiolata, Salvia multiorrhiza Bge, Sophora flavescents Ait, Atractylodes lancea Dc, and combinations thereof. The method comprises treating the vitiligo by orally administering this composition to the patient. The treatment may be further enhanced by topically administering to the affected areas a composition selected from the group consisting of: a preparation of sulfur and kerosene; a preparation of Nevlum oporum and alcohol; a preparation of Cinnamomum cassia prel, Psoralea corylifalia L., alcohol and water; and a preparation of Portulaca oleracea L., brown sugar, and vinegar.
    Type: Application
    Filed: September 17, 2002
    Publication date: April 17, 2003
    Inventor: Huiping Zhao
  • Patent number: 6451358
    Abstract: Compositions and methods for the treatment of vitiligo. The composition comprises at least one member selected from the group consisting of: Eclipta prostrata L., Angelica dahurica (Fish. ex. Hoffm), Polygonum multiforum Thumb, Astragalus complanatus, Tribulus terrestris L., Lithospermum erythrorhizon sieb et zucc, Paris petiolata (Bak. ex Forb), Salvia multiorrhiza Bge, Sophora flavescens Ait, Atractylodes lancea (Thumb) Dc, and combinations thereof. The method comprises treating the vitiligo by orally administering this composition to the patient. The treatment may be further enhanced by topically administering to the affected areas a composition selected from the group consisting of: a preparation of sulfur and kerosene; a preparation of Nevlum oporum solund and alcohol; a preparation of Cinnamomum cassia presl, Psoralea corylifalia L., alcohol and water; and a preparation of Portulaca oleracea L., brown sugar, and vinegar.
    Type: Grant
    Filed: December 28, 2000
    Date of Patent: September 17, 2002
    Assignee: Mileuna, Inc.
    Inventor: Huiping Zhao
  • Publication number: 20010044422
    Abstract: Compositions and methods for the treatment of vitiligo. The composition comprises at least one member selected from the group consisting of: Eclipta prostrata L., Angelica dahurica (Fish. ex. Hoffm), Polygonum multiforum Thumb, Astragalus complanatus, Tribulus terrestris L., Lithospermum erythrorhizon sieb et zucc, Paris petiolata (Bak. ex Forb), Salvia multiorrhiza Bge, Sophora flavescens Ait, Atractylodes lancea (Thumb) Dc, and combinations thereof. The method comprises treating the vitiligo by orally administering this composition to the patient. The treatment may be further enhanced by topically administering to the affected areas a composition selected from the group consisting of: a preparation of sulfur and kerosene; a preparation of Nevlum oporum solund and alcohol; a preparation of Cinnamomum cassia presl, Psoralea corylifalia L., alcohol and water; and a preparation of Portulaca oleracea L., brown sugar, and vinegar.
    Type: Application
    Filed: December 28, 2000
    Publication date: November 22, 2001
    Inventor: Huiping Zhao